| 000 | 01255 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516024656.0 | ||
| 264 | 0 | _c20140425 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1741-203X | ||
| 024 | 7 |
_a10.1017/S1041610211000275 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPassmore, Michael J | |
| 245 | 0 | 0 |
_aSublingual sufentanil for incident pain and dementia-related response agitation. _h[electronic resource] |
| 260 |
_bInternational psychogeriatrics _cJun 2011 |
||
| 300 |
_a844-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Sublingual |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xcomplications |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHip Fractures _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPain, Postoperative _xcomplications |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aPsychomotor Agitation _xetiology |
| 650 | 0 | 4 |
_aSufentanil _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tInternational psychogeriatrics _gvol. 23 _gno. 5 _gp. 844-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S1041610211000275 _zAvailable from publisher's website |
| 999 |
_c20624670 _d20624670 |
||